News & Media
Press releases & statements
Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017
Feb 20, 2017

GAITHERSBURG, Md., Feb. 20, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its fourth quarter and full year 2016 financial and operating results following the close of U.S. financial markets on Monday, February 27, 2017.

Conference call details are as follows:

Date:

 

Monday, February 27, 2017

Time:

 

4:30 p.m. U.S. Eastern Time (ET)

Dial-in number:

 

(877) 212-6076 (Domestic) or (707) 287-9331 (International)

Passcode:

 

61206704

Webcast:

 

www.novavax.com, “Investors”/ “Events”

 

 

 

 

Conference call and webcast replay:

Dates:

 

Starting at 7:30 p.m. ET, February 27, 2017, until midnight March 3, 2017

Dial-in number:

 

(855) 859-2056 (Domestic) or (404) 537-3406 (International)

Passcode:

 

61206704

Webcast:

 

www.novavax.com, “Investors”/ “Events”, until April 30, 2017

 

 

 

 

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.

 

Contact:

Investor Relations
Novavax, Inc.Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir@novavax.com
240-268-2000

Westwicke PartnersJohn Woolfordjohn.woolford@westwicke.com
443-213-0506

Media
Russo Partners, LLCDavid SchullTodd Davenport, Ph.D.
david.schull@russopartnersllc.com
212-845-4271